Biocryst Pharmaceuticals will present new clinical trial and real-world data on its treatments for hereditary angioedema (HAE) at this year’s American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, the company announced. The data include six abstracts reporting updated findings on Orladeyo (berotralstat), an approved oral…
Using Takhzyro (lanadelumab) cut monthly swelling attacks by about 80% in newly treated people with hereditary angioedema (HAE) in Canada, and helped maintain low attack rates among those already on the therapy. Further, the injection treatment was generally well tolerated, with no serious side effects reported. These findings come…
Discussion
We are all programmed in many ways: by our upbringing, our education, our faith and beliefs, our life experiences, and even our diagnoses. Changing my programming to become an empowered rare disease patient and advocate didn’t happen overnight. Long before I was diagnosed with any rare disease, including…
People with type 3 hereditary angioedema (HAE) may report more frequent swelling attacks than people with HAE types 1 or 2, according to a new survey study. The findings also suggest people with HAE type 3 may be more likely to experience potentially life-threatening throat swelling and to report…
Angioedema is the formal medical term for swelling under the skin. It usually occurs as part of an allergic reaction, but has forms that are not due to allergies.
Acute angioedema often occurs as part of an allergic reaction to various allergens or triggers. These can include certain foods, insect bites or stings, medications, and natural rubber products like latex.
Angioedema and hives often occur at the same time. However, angioedema causes large, thick welts which may not be itchy, whereas hives are smaller and usually itchy.
Get regular updates to your inbox.
